Log in

Avadel Pharmaceuticals SEC Filings & 10K Form (NASDAQ:AVDL)

$9.40
+2.28 (+32.02 %)
(As of 02/23/2020 12:54 PM ET)
Today's Range
$8.40
Now: $9.40
$9.64
50-Day Range
$6.42
MA: $7.21
$9.40
52-Week Range
$1.03
Now: $9.40
$9.64
Volume5.80 million shs
Average Volume495,705 shs
Market Capitalization$352.03 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82

SEC Filings

Avadel Pharmaceuticals (NASDAQ:AVDL) SEC Filings

DateFilerForm TypeView
02/17/2020
11:15 PM
Avadel Pharmaceuticals (Filer)
Form EFFECT
02/14/2020
12:48 PM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2020
4:26 PM
Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G/A
02/13/2020
11:38 AM
Avadel Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/05/2020
6:19 AM
Avadel Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/10/2020
4:21 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
1:10 PM
Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
Form SC 13G/A
12/30/2019
2:46 PM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
12/17/2019
7:06 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:21 PM
Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
7:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
7:10 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2019
8:24 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
8:21 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/05/2019
3:30 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:29 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
10:46 AM
Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
Form SC 13G/A
12/05/2019
9:41 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
5:22 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:20 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/02/2019
8:18 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
7:15 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
4:10 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:03 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
4:00 PM
Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:46 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:11 PM
Avadel Pharmaceuticals (Issuer)
Vaughn Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
2:59 PM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:01 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
3:18 PM
Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13D/A
10/04/2019
3:13 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
4:26 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
10:31 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
7:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
7:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
4:05 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:02 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:00 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:58 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:07 PM
Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
12:07 PM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
7:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
7:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:28 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
3:06 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
3:05 PM
Avadel Pharmaceuticals (Issuer)
GUSKY DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:26 PM
Avadel Pharmaceuticals (Filer)
Form DEFA14A
06/13/2019
3:22 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
3:25 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
4:39 PM
Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:10 PM
Avadel Pharmaceuticals (Filer)
Form DEFR14A
05/24/2019
3:08 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
4:00 PM
Avadel Pharmaceuticals (Filer)
Form DEFR14A
05/10/2019
3:46 PM
Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
3:33 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:59 PM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:11 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
4:51 PM
Avadel Pharmaceuticals (Issuer)
DUBOW JORDAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
4:42 PM
Avadel Pharmaceuticals (Issuer)
DUBOW JORDAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2019
3:29 PM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
04/30/2019
3:03 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
12:24 PM
Avadel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
6:16 PM
Avadel Pharmaceuticals (Issuer)
THOMPSON PHILLANDAS T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
6:10 PM
Avadel Pharmaceuticals (Issuer)
KANAN MICHAEL F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
6:07 PM
Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
6:04 PM
Avadel Pharmaceuticals (Issuer)
DIVIS GREG J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2019
3:14 PM
Avadel Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/12/2019
5:01 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
3:00 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2019
7:55 PM
Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
7:49 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
3:09 PM
ANDERSON MICHAEL S (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
11:54 AM
Avadel Pharmaceuticals (Subject)
BRANDES INVESTMENT PARTNERS, LP (Filed by)
Form SC 13G/A
12/18/2018
3:06 PM
Avadel Pharmaceuticals (Issuer)
KANAN MICHAEL F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:04 PM
Avadel Pharmaceuticals (Issuer)
GUSKY DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:01 PM
Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2018
3:03 PM
Avadel Pharmaceuticals (Issuer)
Broadfin Capital, LLC (Reporting)
Broadfin Healthcare Master Fund Ltd (Reporting)
KOTLER KEVIN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2018
4:00 PM
Avadel Pharmaceuticals (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13D
12/11/2018
7:59 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
9:10 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
3:48 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
4:03 PM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
8:04 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2018
10:13 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
7:01 PM
ANDERSON MICHAEL S (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
7:00 PM
Avadel Pharmaceuticals (Issuer)
Hatten Sandra L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
4:08 PM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
8:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
3:21 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:19 PM
Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:17 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
3:15 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2018
3:30 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/27/2018
3:27 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/20/2018
3:11 PM
Avadel Pharmaceuticals (Issuer)
VAN ASSCHE BENOIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
3:08 PM
Avadel Pharmaceuticals (Issuer)
NAVARRE CHRISTOPHE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
3:07 PM
Avadel Pharmaceuticals (Issuer)
FILDES FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2018
3:14 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2018
4:38 PM
Avadel Pharmaceuticals (Issuer)
VAN ASSCHE BENOIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:35 PM
Avadel Pharmaceuticals (Issuer)
STAPLETON CRAIG R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel